Yu Yang, Zhang Yan, Zhu Xi, Zhang Cimin, Tong Chun, Zhao Yangyu
Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China.
Department of Critical Care Medicine, Peking University Third Hospital, Beijing 100191, China. Corresponding author: Zhang Yan, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Mar;33(3):305-310. doi: 10.3760/cma.j.cn121430-20201016-00672.
To observe the effect of fluid therapy on volume and coagulation function in patients with severe postpartum hemorrhage during cesarean section of placenta accreta under the guidance of inferior vena cava diameter (IVCD) and inferior vena cava collapse index (IVC-CI).
A prospective randomized controlled study was conducted in 60 pregnant women with severe postpartum hemorrhage (blood loss ≥ 1 000 mL) who were hospitalized for delivery or referred for delivery in the Peking University Third Hospital from December 2018 to July 2019. The patients were divided into routine fluid replacement group and goal-oriented fluid resuscitation group (goal-oriented fluid replacement therapy was given) according to the different ways of fluid replacement. The hemodynamics, blood gas analysis, coagulation function, total fluid replacement, urine volume, prognosis, intraoperative vasoactive drugs utilization rate and postoperative adverse events were recorded before skin incision, after the fetus delivered, postpartum hemorrhage and at the end of operation, and the differences of these indices between the two groups were compared.
(1) Hemodynamics: the heart rate (HR) of the two groups were reached the peak during postpartum hemorrhage, but there was no significant difference in HR at each time point between the two groups. The mean arterial pressure (MAP) was decreased at first and then increased in both groups, and reached the trough at postpartum hemorrhage, but the MAP in the goal-oriented fluid resuscitation group was significantly higher than that in the routine fluid replacement group [mmHg (1 mmHg = 0.133 kPa): 75.6±10.7 vs. 69.2±8.9, P < 0.05]. In the goal-oriented fluid resuscitation group, the central venous pressure (CVP) was increased slightly after the fetus delivered and then stabilized, while in the routine fluid replacement group, the CVP was increased at first and then decreased, and reached the peak in postpartum hemorrhage. During postpartum hemorrhage, CVP in the goal-oriented fluid resuscitation group was significantly lower than that in the routine fluid replacement group [cmHO (1 cmHO = 0.098 kPa): 9.5±3.9 vs. 11.4±3.4, P < 0.05]. (2) Arterial blood gas: partial pressure of oxygen (PaO) and partial pressure of carbon dioxide (PaCO) in arterial blood at the end of operation in both groups were higher than those in postpartum hemorrhage. There was no significant difference in PaO at the end of operation between the goal-oriented fluid resuscitation group and routine fluid replacement group (mmHg: 189.3±100.5 vs. 240.2±126.3, P > 0.05). The PaCO in the goal-oriented fluid resuscitation group was significantly lower than that in the routine fluid replacement group (mmHg: 34.6±4.6 vs. 36.8±4.1, P < 0.05). The lactic acid (Lac) at the end of operation of the goal-oriented fluid resuscitation group was significantly lower than that of the routine fluid replacement group (mmol/L: 2.2±0.6 vs. 2.6±1.1, P < 0.05). (3) Liquid intake and output volume: the total infusion volume, crystal fluid infusion volume and suspended red blood cell infusion volume in the goal-oriented fluid resuscitation group were significantly less than those in the routine fluid replacement group [total infusion volume (mL): 3 385.9±1 144.1 vs. 4 448.3±1 194.4, crystal infusion volume (mL): 2 635.6±789.7 vs. 3 160.0±860.3, suspended red blood cell input volume (mL): 695.6±366.2 vs. 911.1±284.7, all P < 0.05], and the utilization rate of vasoactive drugs in the goal-oriented fluid resuscitation group was decreased significantly during operation [13.3% (4/30) vs. 60.0% (18/30), P < 0.05]. The amount of bleeding in the goal-oriented fluid resuscitation group was also significantly less than that in the routine fluid replacement group (mL: 1 451.7±373.8 vs. 1 725.9±372.8, P < 0.05), but there was no significant difference in urine volume between the goal-oriented fluid resuscitation group and the routine fluid replacement group (mL: 369.0±262.7 vs. 485.0±286.8, P > 0.05). (4) Coagulation function: at the end of operation, the prothrombin time (PT) in the goal-oriented fluid resuscitation group was significantly shorter than that in the routine fluid replacement group (s: 10.9±0.6 vs. 11.2±0.6), and the fibrinogen (Fib) in the goal-oriented fluid resuscitation group was significantly higher than that in the routine fluid replacement group (g/L: 3.7±0.5 vs. 2.9±0.8), and the differences were statistically significant (both P < 0.05). (5) Prognostic index: compared with the routine fluid replacement group, the proportion of patients transferred to intensive care unit (ICU) at the end of operation in the goal-oriented fluid resuscitation group was significantly lower [16.7% (5/30) vs. 66.7% (20/30), P < 0.05], and ICU length-of-stay was significantly shorter [hours: 0 (0, 24) vs. 24 (0, 24), P < 0.05], but there was no significant difference in the incidence of disseminated intravascular coagulation (DIC), acute renal injury (AKI) or hysterectomy between the goal-oriented fluid resuscitation group and the routine fluid replacement group [the incidence of DIC: 0% (0/30) vs. 6.7% (2/30), the incidence of AKI: 0% (0/30) vs. 3.3% (1/30), the hysterectomy rate: 10.0% (3/30) vs. 26.7% (8/30), all P > 0.05].
Fluid resuscitation guided by IVC-CI can effectively reduce the volume of blood and fluid transfusion and blood loss in patients with severe postpartum hemorrhage and improve their blood coagulation function.
观察在腔静脉直径(IVCD)和腔静脉塌陷指数(IVC-CI)指导下的液体治疗对胎盘植入剖宫产术中严重产后出血患者血容量及凝血功能的影响。
对2018年12月至2019年7月在北京大学第三医院住院分娩或转诊分娩的60例严重产后出血(失血≥1000 mL)孕妇进行前瞻性随机对照研究。根据不同的补液方式将患者分为常规补液组和目标导向性液体复苏组(给予目标导向性液体替代治疗)。记录皮肤切开前、胎儿娩出后、产后出血时及手术结束时的血流动力学、血气分析、凝血功能、总补液量、尿量、预后、术中血管活性药物使用率及术后不良事件,并比较两组间这些指标的差异。
(1)血流动力学:两组心率(HR)均在产后出血时达到峰值,但两组各时间点HR差异无统计学意义。两组平均动脉压(MAP)均先降低后升高,在产后出血时达到低谷,但目标导向性液体复苏组MAP显著高于常规补液组[mmHg(1 mmHg = 0.133 kPa):75.6±10.7 vs. 69.2±8.9,P < 0.05]。目标导向性液体复苏组胎儿娩出后中心静脉压(CVP)略有升高然后稳定,而常规补液组CVP先升高后降低,在产后出血时达到峰值。产后出血时,目标导向性液体复苏组CVP显著低于常规补液组[cmH₂O(1 cmH₂O = 0.098 kPa):9.5±3.9 vs. 11.4±3.4,P < 0.05]。(2)动脉血气:两组手术结束时动脉血氧分压(PaO₂)和动脉血二氧化碳分压(PaCO₂)均高于产后出血时。目标导向性液体复苏组与常规补液组手术结束时PaO₂差异无统计学意义(mmHg:189.3±100.5 vs. 240.2±126.3,P > 0.05)。目标导向性液体复苏组PaCO₂显著低于常规补液组(mmHg:34.6±4.6 vs. 36.8±4.1,P < 0.05)。目标导向性液体复苏组手术结束时乳酸(Lac)显著低于常规补液组(mmol/L:2.2±0.6 vs. 2.6±1.1,P < 0.05)。(3)液体出入量:目标导向性液体复苏组总输液量、晶体液输液量和悬浮红细胞输液量均显著少于常规补液组[总输液量(mL):3385.9±1144.1 vs. 4448.3±1194.4,晶体液输液量(mL):2635.6±789.7 vs. 3160.0±860.3,悬浮红细胞输入量(mL):695.6±366.2 vs. 911.1±284.7,均P < 0.05],且目标导向性液体复苏组术中血管活性药物使用率显著降低[13.3%(4/30)vs. 60.0%(18/30),P < 0.05]。目标导向性液体复苏组出血量也显著少于常规补液组(mL:1451.7±373.8 vs. 1725.9±372.8,P < 0.05),但目标导向性液体复苏组与常规补液组尿量差异无统计学意义(mL:369.0±262.7 vs. 485.0±286.8,P > 0.05)。(4)凝血功能:手术结束时,目标导向性液体复苏组凝血酶原时间(PT)显著短于常规补液组(s:10.9±0.6 vs. 11.2±0.6),目标导向性液体复苏组纤维蛋白原(Fib)显著高于常规补液组(g/L:3.7±0.5 vs. 2.9±0.8),差异均有统计学意义(均P < 0.05)。(5)预后指标:与常规补液组相比,目标导向性液体复苏组手术结束时转入重症监护病房(ICU)的患者比例显著降低[16.7%(5/30)vs. 66.7%(20/30),P < 0.05],ICU住院时间显著缩短[小时:0(0,24)vs. 24(0,24),P < 0.05],但目标导向性液体复苏组与常规补液组弥散性血管内凝血(DIC)、急性肾损伤(AKI)或子宫切除术发生率差异无统计学意义[DIC发生率:0%(0/30)vs. 6.7%(2/30),AKI发生率:0%(0/30)vs. 3.3%(1/30),子宫切除率:10.0%(3/30)vs. 26.7%(8/30),均P > 0.05]。
IVC-CI指导下的液体复苏可有效减少严重产后出血患者的血液及液体输注量和失血量,并改善其凝血功能。